Charles River Laboratories: Deutsche Bank raises target price to $320 from $300
CRL•Deutsche Bank raised its target price for Charles River Laboratories to $320 from $300.
Related News
BlackRock tops 5% stake in Mercialys, holds 5.04% voting rights
BLK•
Fate Therapeutics wins $15 million CIRM grant for FT819 lupus nephritis Phase 2 trial
FATE•
Microsoft revamps Copilot with code generation, agentic AI tools
MSFT•
AI allure seduces the sedate side of investing
XLI•
Core Scientific appoints Jay Elms chief commercial officer
CORZ•